$ Value
$16K
Shares
3,796
Price
$4
Filed
May 19
Insider
Name
Khan Najat
Title
Chief R&D Commercial Officer
CIK
0002020969
Roles
Transaction Details
Transaction Date
2025-05-15
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
708,585
Footnotes
Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units. | The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. | This option vests as to one fourth (1/4th) of the shares subject to the option on July 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter subject to Reporting Person's continued service to the Issuer through each such vesting date.
Filing Info
Khan Najat's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-22 | RXRX | ▼ | $549K |
| 2025-11-17 | RXRX | F | $73K |
| 2025-11-05 | RXRX | A | $0 |
| 2025-11-05 | RXRX | A | $0 |
| 2025-08-18 | RXRX | ▼ | $202K |
| 2025-08-15 | RXRX | F | $21K |
| 2025-05-15 | RXRX | F | $16K |
Other Insiders at RXRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Taylor Ben R
Chief Financial Officer
|
— | — | 2026-04-06 |
| Li Dean Y | — | — | 2026-04-01 |
| Dar Zavain | — | — | 2026-04-01 |
| Borgeson Blake | — | $93K | 2026-04-07 |
| Gibson Christopher | — | $254K | 2026-04-07 |